Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Audrey Kinahan"'
Publikováno v:
The Journal of clinical endocrinology and metabolism. 107(9)
Abuse of androgens and erythropoietin has led to hormones being the most effective and frequent class of ergogenic substances prohibited in elite sports by the World Anti-Doping Agency (WADA). At present, thyroid hormone (TH) abuse is not prohibited,
Autor:
Audrey Kinahan, Mark Stuart
Publikováno v:
Emerging Drugs in Sport ISBN: 9783030792923
Emerging Drugs in Sport
Emerging Drugs in Sport
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de5317d8fc10c8e219e2dedd1c75fdc2
https://doi.org/10.1007/978-3-030-79293-0_19
https://doi.org/10.1007/978-3-030-79293-0_19
Autor:
Martine Duclos, Audrey Kinahan, Richard Budgett, Katja Mjøsund, Christian J. Strasburger, P. R. Harcourt, Alan Vernec, Andrew Slack
Publikováno v:
British Journal of Sports Medicine
The use of systemic glucocorticoids (GCs), as well as local injections, continues to be a controversial issue in the sport/anti-doping community. There is widespread and legitimate use of GCs for numerous health conditions, yet there are concerns abo
Publikováno v:
Medicine and sport science. 62
The list of prohibited substances and methods (the List) is the international standard that determines what is prohibited in sport both in- and out-of-competition. Since 2004, the official text of the List is produced by the World Anti-Doping Agency
The list of prohibited substances and methods (the List) is the international standard that determines what is prohibited in sport both in- and out-of-competition. Since 2004, the official text of the List is produced by the World Anti-Doping Agency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb6581fab519fe6088843f992b3d4d50
https://doi.org/10.1159/000460699
https://doi.org/10.1159/000460699
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781468460384
Methods of comparing in vitro dissolution profile data are of interest in the development of Extended Release dosage formulations. One is usually interested in determining if the dissolution profile for the Test formulation is significantly different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e64569010d7c266634a3095d8d9ef04f
https://doi.org/10.1007/978-1-4684-6036-0_14
https://doi.org/10.1007/978-1-4684-6036-0_14